United Therapeutics Insider Discloses 4,000-Share Sale on NASDAQ

Rhea-AI Filing Summary

UNITED THERAPEUTICS (UTHR) Form 144 shows a proposed sale of 4,000 common shares through TD Securities on NASDAQ with an aggregate market value of $1,591,535.70. The filer reports acquiring 294,000 shares on 03/15/2016 under an executive deferred compensation arrangement, where shares were issued via vested option exercises and payment made in common shares. The filing also discloses recent open-market sales by Martine Rothblatt totaling 20,000 shares across 09/09–09/12/2025 with combined gross proceeds reported on each trade. The notice includes the standard insider representation about lack of undisclosed material information.

Positive

• None.

Negative

• Insider sales disclosed: The filing reports ongoing dispositions by an insider (20,000 shares sold in the past four days and a proposed sale of 4,000 shares), which investors may view as a negative signal despite limited scale relative to total shares outstanding.

Insights

Securities Analyst

TL;DR: Insider sale disclosed; size is small relative to outstanding shares, suggesting limited market impact.

The filing indicates a planned sale of 4,000 common shares valued at about $1.59M, executed through TD Securities on NASDAQ. Recent disclosed sales by the same insider total 20,000 shares over four trading days, with individual trade proceeds reported. Relative to the reported 45,230,000 shares outstanding, these transactions represent a de minimis percentage of the float and are unlikely to alter valuation metrics materially. The acquisition history shows the shares originated from an executive deferred compensation plan in 2016, not recent grants, which is relevant to assessing insider motivation but does not provide evidence of undisclosed company issues.

Corporate Governance Expert

TL;DR: Disclosure meets Rule 144 format; repeated sales should prompt routine governance monitoring.

The Form 144 is properly completed with broker, exchange, and proposed sale details, and includes the statutory insider certification. Multiple sales across consecutive days by the same insider are disclosed, which is common for planned dispositions executed through an agent. From a governance perspective, these filings warrant standard oversight—confirming adherence to any company blackout policies and checking for documented trading plans—but the filing itself contains no allegation or indication of governance breaches.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	TD SECURITIES (USA) LLC 125 PARK AVE, 20Th Floor New York NY 10017	4000	1591535.70	45230000	09/15/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/15/2016	Executive Deferred Compensation	Martine Rothblatt			294000	03/15/2016	Shares exercised via vested options and payment made via common shares

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Martine Rothblatt 1000 Spring Street Silver Spring MD 20910	Common	09/09/2025	8000	3188374.33
Martine Rothblatt 1000 Spring Street Silver Spring MD 20910	Common	09/10/2025	4000	1594872.82
Martine Rothblatt 1000 Spring Street Silver Spring MD 20910	Common	09/11/2025	4000	1588904.00
Martine Rothblatt 1000 Spring Street Silver Spring MD 20910	Common	09/12/2025	4000	1615897.79

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many shares does the Form 144 propose to sell for UTHR?

The notice proposes the sale of 4,000 common shares through TD Securities on NASDAQ.

What is the aggregate market value of the proposed sale on the Form 144?

The aggregate market value reported for the proposed sale is $1,591,535.70.

Who is the seller and what recent sales did they report?

The seller linked in the filing is Martine Rothblatt; the filing discloses four recent sales on 09/09–09/12/2025 totaling 20,000 shares with gross proceeds reported for each trade.

How were the shares acquired according to the filing?

The filer acquired 294,000 shares on 03/15/2016 under an executive deferred compensation arrangement, via vested option exercises with payment made in common shares.

Through which broker and exchange will the proposed sale occur?

The proposed sale lists TD Securities (USA) LLC as the broker and NASDAQ as the exchange.